The Quantellect read.As of Nov 19, 2026, 15 active firms cover RXO Inc: 5 rate it Buy or better, 10 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets span $19.00 to $35.00, a moderate spread. The average target of $27.66 sits 3% below the current $28.63. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 3 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.02 next quarter toward $0.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 active firms
Neutral
Strong Buy00%
Buy533%
Neutral1067%
Sell00%
Strong Sell00%
Based on 15 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$27.66
-3.4% downside
Average target across 14 active firms as of Nov 19, 2026 vs $28.63 current
Highest Target$35.00
Average Target$27.66
Lowest Target$19.00
Detailed analyst forecasts for RXO
Showing 1–15 of 15 named analysts shown · 15 active firms in the rating projection
As of Nov 19, 2026, 5 of 15 active firms rate RXO a Buy (10 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
RXO EPS & revenue forecast
EPS · NEXT QUARTER
$0.02
Range $-0.04 – $0.09 · 12 analysts · -126% YoY
Next period, 12 analysts expect RXO Inc. to earn $0.02 a share (range $-0.04 – $0.09), versus $-0.09 a year earlier. Full-year consensus is $0.16, growing to $0.66 the year after.
REVENUE · NEXT QUARTER
$1.7B
Range $1.5B – $1.9B · 12 analysts · +20% YoY
Revenue is expected to reach $1.7B (range $1.5B – $1.9B), +20.4% year-over-year. Full-year consensus is $7.0B, rising to $7.7B next year.
Top analysts covering RXO Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RXO.
#1
Brandon Oglenski
Barclays · Rank #86
Buy
$28.00-2.2% to target
Overall win rate
45%
+ Follow
#2
Thomas Wadewitz
UBS · Rank #153
Neutral
No targeton RXO
Overall win rate
42%
+ Follow
#3
Ken Hoexter
B of A Securities · Rank #269
Neutral
$27.00-5.7% to target
Overall win rate
46%
+ Follow
#4
Brian Ossenbeck
JP Morgan · Rank #383
Neutral
$30.00+4.8% to target
Overall win rate
37%
+ Follow
#5
Stephanie Moore
Jefferies · Rank #462
Neutral
$30.00+4.8% to target
Overall win rate
37%
+ Follow
RXO stock forecast FAQ
What is RXO's average 12-month price target?+
The 14 active firms with a live target average $27.66 for RXO Inc. over the next 12 months, ranging from a $35.00 high to a $19.00 low, as of Nov 19, 2026.
Is RXO stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 15 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 10 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for RXO?+
The Street-high target is $35.00 (BMO Capital), and the Street-low is $19.00 (Susquehanna). The average of all 14 active-firm targets is $27.66.
How many active Wall Street firms cover RXO?+
15 active firms have a recognized rating on RXO Inc. as of Nov 19, 2026, and 14 active firms carry a live 12-month price target.
Who is the most accurate analyst covering RXO?+
Among analysts who currently cover RXO, Brandon Oglenski of Barclays has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $28.00 target.
What is RXO Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.02 per share (range $-0.04 – $0.09) across 12 analysts. Full-year EPS is projected at $0.16, rising to $0.66 the following year.
How much revenue is RXO Inc. expected to report next quarter?+
Consensus revenue is $1.7B (range $1.5B – $1.9B). Full-year revenue is projected at $7.0B, growing to $7.7B next year.
Have analysts been upgrading or downgrading RXO lately?+
As of Nov 19, 2026, 5 of 15 active firms rate RXO a Buy (10 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RXO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.